Login
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
.......... Issued in the interest of Investors"
OTP Verification
Regenerate OTP
Alert Message
Please contact to emkayassist@emkayglobal.com
Select Mobile Number and Email for OTP
Please select Mobile No and Email Id for OTP
Generate password
Customer Guest
Login | Register
Forgot Customer Code
Login | Register|Forgot password?
Would you like to create a personalised login id for logging in to Emkay Website ?
Change Personalised Login ID
Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider...more...
As of June 2026 75.00% is owned by Indian Promoters and 25.00% by Public. Top five Promoters holding highest number of shares of Bafna Pharm...more...
Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018 for the quarter...more...
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026.more...
Bafna Pharmaceuticals Limitedÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India...more...
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tradin...more...
Bafna Pharmaceuticals Limited has informed the Exchange about retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company...more...
Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term wit...more...
Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term with effect ...more...
Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Audited Financial Results of the Company...more...
The company reported standalone net profit of Rs 2.75 crore for the quarter ended March 31 2026 as compared to Rs 1.31 crore in the same period last ...more...
We herewith enclose the Audited Financial Results of the Company along with the Statutory Auditor s Report for the Quarter and Year ended Ma...more...
We hereby inform you that the Board of Directors in their meeting held on May 29 2026 inter-alia considered and approved the Audited Financial Result...more...
SRJR Lifesciences LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indi...more...
Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider...more...
As of March 2026 75.00% is owned by Indian Promoters and 25.00% by Public. Top five Promoters holding highest number of shares of Bafna Phar...more...
Significant movement in price has been observed in Bafna Pharmaceuticals Limited. The Exchange in order to ensure that investors have latest relevant...more...
We hereby submit our response to the Clarification sought by the Stock Exchange regarding the movement in the Share Price of the Company.more...
The Exchange has sought clarification from Bafna Pharmaceuticals Ltd on April 13 2026 with reference to significant movement in price in ord...more...
BOARD MEETINGS Company Name : Shree Ram Proteins Date : 17-08-2026
Latest Videos